Ligand validation:8IR9

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IR9_SQD_a_410	70%	31%	0.135	0.953	0.95	1.77	3	13	0	0	100%	0.4
8IR9_SQD_A_410	69%	31%	0.128	0.943	0.93	1.81	3	10	0	0	100%	0.4
8IR9_SQD_L_101	43%	29%	0.145	0.866	1.06	1.75	4	10	0	0	100%	1
8IR9_SQD_F_103	37%	20%	0.176	0.911	1.19	2.14	4	14	0	0	80%	0.7963
8IR9_SQD_b_620	32%	31%	0.165	0.835	1.05	1.69	3	12	0	0	100%	1
8IR9_SQD_a_411	30%	42%	0.186	0.847	1.07	1.19	3	8	0	0	100%	1
8IR9_SQD_A_412	27%	42%	0.185	0.831	1.02	1.24	3	6	0	0	100%	1
8IR9_SQD_f_102	7%	31%	0.307	0.799	1.18	1.57	3	11	0	0	80%	0.7963
5V2C_SQD_a_413	94%	21%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	78%	20%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	29%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	76%	31%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	76%	29%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	31%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.